16
Assessment
4.7. Exercise and Functional Capacity Testing
COR LOE
Recommendations
1 C-LD 1. In patients with HF, assessment and documentation of
NYHA functional classification are recommended to
determine eligibility for treatments.
1 C-LD 2. In selected ambulatory patients with HF, cardiopulmonary
exercise testing (CPET) is recommended to determine
appropriateness of advanced treatments (e.g., LVAD, heart
transplant).
2a C-LD 3. In ambulatory patients with HF, performing a CPET or 6-
minute walk test is reasonable to assess functional capacity.
2a C-LD 4. In ambulatory patients with unexplained dyspnea, CPET is
reasonable to evaluate the cause of dyspnea.
4.8. Initial and Serial Evaluation: Clinical Assessment:
HF Risk Scoring
COR LOE
Recommendation
2a B-NR 1. In ambulatory or hospitalized patients with HF, validated
multivariable risk scores can be useful to estimate subsequent
risk of mortality.
